These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 25688158)

  • 1. Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALL.
    Stubbs MC; Kim W; Bariteau M; Davis T; Vempati S; Minehart J; Witkin M; Qi J; Krivtsov AV; Bradner JE; Kung AL; Armstrong SA
    Clin Cancer Res; 2015 May; 21(10):2348-58. PubMed ID: 25688158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma.
    Buurman R; Sandbothe M; Schlegelberger B; Skawran B
    Eur J Med Res; 2016 Jun; 21(1):26. PubMed ID: 27342975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cells.
    Kiweler N; Brill B; Wirth M; Breuksch I; Laguna T; Dietrich C; Strand S; Schneider G; Groner B; Butter F; Heinzel T; Brenner W; Krämer OH
    Arch Toxicol; 2018 Jul; 92(7):2227-2243. PubMed ID: 29845424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective Inhibitors of Histone Deacetylases 1 and 2 Synergize with Azacitidine in Acute Myeloid Leukemia.
    Min C; Moore N; Shearstone JR; Quayle SN; Huang P; van Duzer JH; Jarpe MB; Jones SS; Yang M
    PLoS One; 2017; 12(1):e0169128. PubMed ID: 28060870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Class I Histone Deacetylases 1 and 2 Promotes Urothelial Carcinoma Cell Death by Various Mechanisms.
    Pinkerneil M; Hoffmann MJ; Deenen R; Köhrer K; Arent T; Schulz WA; Niegisch G
    Mol Cancer Ther; 2016 Feb; 15(2):299-312. PubMed ID: 26772204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A toolbox for class I HDACs reveals isoform specific roles in gene regulation and protein acetylation.
    Hess L; Moos V; Lauber AA; Reiter W; Schuster M; Hartl N; Lackner D; Boenke T; Koren A; Guzzardo PM; Gundacker B; Riegler A; Vician P; Miccolo C; Leiter S; Chandrasekharan MB; Vcelkova T; Tanzer A; Jun JQ; Bradner J; Brosch G; Hartl M; Bock C; Bürckstümmer T; Kubicek S; Chiocca S; Bhaskara S; Seiser C
    PLoS Genet; 2022 Aug; 18(8):e1010376. PubMed ID: 35994477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to Distinguish Between the Activity of HDAC1-3 and HDAC6 with Western Blot.
    Beyer M; Kiweler N; Mahboobi S; Krämer OH
    Methods Mol Biol; 2017; 1510():355-364. PubMed ID: 27761834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDAC1 and HDAC2 regulate anti-inflammatory effects of anesthetic isoflurane in human monocytes.
    Guo X; Deng J; Zheng B; Liu H; Zhang Y; Ying Y; Jia J; Ruan X
    Immunol Cell Biol; 2020 Apr; 98(4):318-331. PubMed ID: 31950542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of STAT1-Driven Transcriptional Activity by Histone Deacetylases.
    Owusu BY; Klampfer L
    Methods Mol Biol; 2017; 1510():277-285. PubMed ID: 27761828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myeloma.
    Kikuchi J; Wada T; Shimizu R; Izumi T; Akutsu M; Mitsunaga K; Noborio-Hatano K; Nobuyoshi M; Ozawa K; Kano Y; Furukawa Y
    Blood; 2010 Jul; 116(3):406-17. PubMed ID: 20351311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective HDAC1/HDAC2 inhibitors induce neuroblastoma differentiation.
    Frumm SM; Fan ZP; Ross KN; Duvall JR; Gupta S; VerPlank L; Suh BC; Holson E; Wagner FF; Smith WB; Paranal RM; Bassil CF; Qi J; Roti G; Kung AL; Bradner JE; Tolliday N; Stegmaier K
    Chem Biol; 2013 May; 20(5):713-25. PubMed ID: 23706636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDAC1 and HDAC2 collectively regulate intestinal stem cell homeostasis.
    Zimberlin CD; Lancini C; Sno R; Rosekrans SL; McLean CM; Vlaming H; van den Brink GR; Bots M; Medema JP; Dannenberg JH
    FASEB J; 2015 May; 29(5):2070-80. PubMed ID: 25648995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective HDAC inhibition for the disruption of latent HIV-1 infection.
    Barton KM; Archin NM; Keedy KS; Espeseth AS; Zhang YL; Gale J; Wagner FF; Holson EB; Margolis DM
    PLoS One; 2014; 9(8):e102684. PubMed ID: 25136952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposed regulation of type I IFN-induced STAT3 and ISGF3 transcriptional activities by histone deacetylases (HDACS) 1 and 2.
    Icardi L; Lievens S; Mori R; Piessevaux J; De Cauwer L; De Bosscher K; Tavernier J
    FASEB J; 2012 Jan; 26(1):240-9. PubMed ID: 21957129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, Synthesis and Biological Evaluation of New HDAC1 and HDAC2 Inhibitors Endowed with Ligustrazine as a Novel Cap Moiety.
    Al-Sanea MM; Gotina L; Mohamed MF; Grace Thomas Parambi D; Gomaa HAM; Mathew B; Youssif BGM; Alharbi KS; Elsayed ZM; Abdelgawad MA; Eldehna WM
    Drug Des Devel Ther; 2020; 14():497-508. PubMed ID: 32103894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Histone Deacetylase Inhibition on the Expression of Multidrug Resistance-associated Protein 2 in a Human Placental Trophoblast Cell Line.
    Duan HY; Ma D; Zhou KY; Wang T; Zhang Y; Li YF; Wu JL; Hua YM; Wang C
    Chin Med J (Engl); 2017 Jun; 130(11):1352-1360. PubMed ID: 28524836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDAC Inhibitor-Induced Mitotic Arrest Is Mediated by Eg5/KIF11 Acetylation.
    Nalawansha DA; Gomes ID; Wambua MK; Pflum MKH
    Cell Chem Biol; 2017 Apr; 24(4):481-492.e5. PubMed ID: 28392145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Karyotypically abnormal human ESCs are sensitive to HDAC inhibitors and show altered regulation of genes linked to cancers and neurological diseases.
    Lund RJ; Emani MR; Barbaric I; Kivinen V; Jones M; Baker D; Gokhale P; Nykter M; Lahesmaa R; Andrews PW
    Stem Cell Res; 2013 Nov; 11(3):1022-36. PubMed ID: 23941963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podocyte histone deacetylase activity regulates murine and human glomerular diseases.
    Inoue K; Gan G; Ciarleglio M; Zhang Y; Tian X; Pedigo CE; Cavanaugh C; Tate J; Wang Y; Cross E; Groener M; Chai N; Wang Z; Justice A; Zhang Z; Parikh CR; Wilson FP; Ishibe S
    J Clin Invest; 2019 Mar; 129(3):1295-1313. PubMed ID: 30776024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosage-dependent tumor suppression by histone deacetylases 1 and 2 through regulation of c-Myc collaborating genes and p53 function.
    Heideman MR; Wilting RH; Yanover E; Velds A; de Jong J; Kerkhoven RM; Jacobs H; Wessels LF; Dannenberg JH
    Blood; 2013 Mar; 121(11):2038-50. PubMed ID: 23327920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.